Site reference ID 226 — Silver Spring, Maryland

Site reference ID 226 is a clinical research site located in Silver Spring, Maryland, United States 20910.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Site reference ID 226 has participated in 1 clinical trials.

Therapeutic areas: Uterine Fibroids, Heavy Menstrual Bleeding.

Sponsors: ObsEva SA.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Silver Spring

Browse all research sites in Maryland · View every site in Silver Spring

• Holy Cross Hospital
• Children's National Hospital
• Holy Cross Hospital Holy Cross
• Holy Cross Hospital /ID# 275872
• Holy Cross Hospital Health Center
• Holy Cross Hospital Resource Center
• Holy Cross Hospital Hospital Pharmacy
• Holy Cross Hospital, Pharmacy
• Childrens National Hospital
• Holy Cross Hospital, Silver Spring
• Holy Cross Hospital of Silver Spring
• Holy Cross Hospital Resource Center Department of Cancer Research

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Site reference ID 226?

Site reference ID 226 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Site reference ID 226 conducted?

Site reference ID 226 has 1 clinical trials on record. Their work covers Uterine Fibroids, Heavy Menstrual Bleeding.

Is Site reference ID 226 accredited by Crixeo Clinical Trials?

Site reference ID 226 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Site reference ID 226?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.